Article Details

Moderna Outlines Strategy to Address SARS-CoV-2 Variants; Ships Variant Booster to NIH for ...

Retrieved on: 2021-02-25 14:37:30

Tags for this article:

Click the tags to see associated articles and topics

Moderna Outlines Strategy to Address SARS-CoV-2 Variants; Ships Variant Booster to NIH for .... View article details on HISWAI: https://www.empr.com/home/news/drugs-in-the-pipeline/moderna-outlines-strategy-to-address-sars-cov-2-variants-ships-variant-booster-to-nih-for-testing/

Excerpt

Currently, the mRNA-1273 (100μg) vaccine is authorized as a 2-dose series given 28 days apart. The Company also plans to evaluate mRNA-1273.351 ...

Article found on: www.empr.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up